* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 1 - PBL Group 14
Survey
Document related concepts
Western blot wikipedia , lookup
Drug discovery wikipedia , lookup
Drug design wikipedia , lookup
Node of Ranvier wikipedia , lookup
Biochemical cascade wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Chemical synapse wikipedia , lookup
Magnesium in biology wikipedia , lookup
Paracrine signalling wikipedia , lookup
Lipid signaling wikipedia , lookup
Endocannabinoid system wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Metalloprotein wikipedia , lookup
Transcript
1. Describe the major types of target proteins on which drugs act. (Refer to Fig 3.1 Rang & Dale’s Pharmacology, p.25) kgkgkjg The majority of protein targets for drug action on mammalian cells can be broadly divided into 4 catagories: Receptors Receptors are the sensing elements in the system of chemical communications that coordinates the function of all the different cells in the body, the chemical messengers being the various hormones, transmitters and other mediators. Many therapeutically useful drugs act, either as agonists or antagonists, on receptors for known endogenous mediators. Drugs act on receptors in two main ways: Agonist Antagonist Ion channels Some ion channels (known as ligand-gated ion channels) incorporate a receptor and open only when the receptor is occupied by an agonist; others are gated by different mechanisms, voltage-gated ion channels being particularly important. In general, drugs can affect ion channel function by interacting either with the receptor site of ligand-gated channels, or with other parts of the channel molecule thus making them a protein target separate from their own receptors. The interaction can be indirect, involving a G-protein and other intermediaries, or direct, where the drug itself binds to the channel protein and alters its function. In the simplest case, exemplified by the action of local anaesthetics on the voltage-gated sodium channel the drug molecule plugs the channel physically blocking ion permeation. Drugs affect ion channels in two main ways: Blockers Modulators Enzymes Many drugs are targeted on enzymes. Often, the drug molecule is a substrate analogue that acts as a competitive inhibitor of the enzyme; in other cases, the binding is irreversible and non-competitive (e.g. aspirin , acting on cyclo-oxygenase). Drugs may also act as false substrates, where the drug molecule undergoes chemical transformation to form an abnormal product that subverts the normal metabolic pathway. It should also be mentioned that drugs may require enzymic degradation to convert them from an inactive form, the prodrug, to an active form. Furthermore, drug toxicity often results from the enzymic conversion of the drug molecule to a reactive metabolite. As far as the primary action of the drug is concerned, this is an unwanted side reaction, but it is of major practical importance. Inhibitor False Substrate Pro-drug Carrier molecules The transport of ions and small organic molecules across cell membranes generally requires a carrier protein, because the permeating molecules are often too polar (i.e. insufficiently lipid-soluble) to penetrate lipid membranes on their own. There are many examples of such carriers, including those responsible for the transport of glucose and amino acids into cells, the transport of ions and many organic molecules by the renal tubule, the transport of Na+ and Ca2+ out of cells, and the uptake of neurotransmitter precursors (such as choline) or of neurotransmitters themselves (such as noradrenaline, 5-hydroxytryptamine [5-HT], glutamate, and peptides) by nerve terminals. The amine transporters belong to a well-defined structural family, distinct from the corresponding receptors. In most cases, the transport of organic molecules is coupled to the transport of ions (usually Na+), either in the same direction (symport) or in the opposite direction (antiport). The carrier proteins embody a recognition site that makes them specific for a particular permeating species, and these recognition sites can also be targets for drugs whose effect is to block the transport system. Normal Transport (business as usual) Inhibitor False Substrate 2. Describe the Structure and Activity of Receptors and Ion Channels Receptors Receptors elicit many different types of cellular effect. Some of them are very rapid, such as those involved in synaptic transmission, operating within milliseconds, whereas other receptor-mediated effects, such as those produced by thyroid hormone or various steroid hormones, occur over hours or days. Based on molecular structure and the nature of this linkage (the transduction mechanism), we can distinguish four receptor types: Type 1: ligand-gated ion channels Type 2: G-protein-coupled receptors Type 3: kinase-linked and related receptors Type 4: nuclear receptors. (these receptors are discussed below under receptor-effector likages) Ion Channels We have discussed ligand-gated ion channels as one of the four main types of drug receptor. There are many other types of ion channel that represent important drug targets, even though they are not generally classified as 'receptors' because they are not the immediate targets of fast neurotransmitters. Ions are unable to penetrate the lipid bilayer of the cell membrane, and can get across only with the help of membrane-spanning proteins in the form of channels or transporters. Ion channels consist of protein molecules designed to form water-filled pores that span the membrane to avoid the polarity of the lipid bi-layer, and can switch between open and closed states. The rate and direction of ion movement through the pore is governed by the electrochemical gradient for the ion in question, which is a function of its concentration on either side of the membrane, and of the membrane potential. Ion channels are characterised by: their selectivity for particular ion species, determined by the size of the pore and the nature of its lining their gating properties (i.e. the nature of the stimulus that controls the transition between open and closed states of the channel) their molecular architecture. SELECTIVITY Channels are generally either cation-selective or anion-selective. Cation-selective channels may be selective for Na+, Ca2+ or K+, or non-selective and permeable to all three. Anion channels are mainly permeable to Cl-, although other types also occur. GATING Voltage-gated channels These channels open when the cell membrane is depolarised. They form a very important group because they underlie the mechanism of membrane excitability. The most important channels in this group are selective sodium, potassium or calcium channels. Ligand-gated channels These are activated by binding of a chemical ligand to a site on the channel molecule. Fast neurotransmitters, such as glutamate, acetylcholine, GABA and ATP act in this way, binding to sites on the outside of the membrane. The vanilloid receptor TRPV1 mediates the pain-producing effect of capsaicin on sensory nerves. Some ligand-gated channels in the plasma membrane respond to intracellular rather than extracellular signals, the most important being the following. Calcium-activated potassium channels, which occur in most cells, and open, thus hyperpolarising the cell, when [Ca2+]i increases. ATP-sensitive potassium channels, which open when the intracellular ATP concentration falls because the cell is short of nutrients. These channels, which are quite distinct from those mediating the excitatory effects of extracellular ATP, occur in many nerve and muscle cells, and also in insulin-secreting cells. Calcium release channels These are present on the endoplasmic or sarcoplasmic reticulum rather than the plasma membrane. The main ones, IP3 and ryanodine receptors are a special class of ligand-gated calcium channels that control the release of Ca2+ from intracellular stores. Store-operated calcium channels When the intracellular Ca2+ stores are depleted, channels in the plasma membrane open to allow Ca2+ entry. The mechanism by which this linkage occurs is poorly understood, but store-operated calcium channels (SOCs) are important in the mechanism of action of many GPCRs that elicit Ca2+ release. The opening of SOCs allows [Ca2+]i to remain elevated even when the stores are running low, and also provides a route through which the stores can be replenished 3. Describe the various forms of receptor-effector linkages p.31 Type 1: ligand-gated ion channels (Milliseconds). These are membrane proteins with a similar structure to other ion channels, and incorporate a ligand-binding (receptor) site, usually in the extracellular domain. Receptors of this type control the fastest synaptic events in the nervous system, in which a neurotransmitter acts on the postsynaptic membrane of a nerve or muscle cell and transiently increases its permeability to particular ions. Most excitatory neurotransmitters, such as acetylcholine at the neuromuscular junction cause an increase in Na+ and K+ permeability. This results in a net inward current carried mainly by Na+, which depolarizes the cell and increases the probability that it will generate an action potential. Type 2: G-protein-coupled receptors (Seconds) (GPCRs). They are membrane receptors that are coupled to intracellular effector systems via a Gprotein. They constitute the largest family, and include receptors for many hormones and slow transmitters. GPCRs function through a mechanism involving a G-protein. The most obvious difference is that a photon, rather than an agonist molecule, produces the response. The protein has its own inbuilt agonist molecule which isomerises from the trans (inactive) to the cis (active) form when it absorbs a photon. Type 3: kinase-linked and related receptors (Hours) This is a large and heterogeneous group of membrane receptors responding mainly to protein mediators. They comprise an extracellular ligand-binding domain linked to an intracellular domain by a single transmembrane helix. In many cases, the intracellular domain is enzymic in nature (with protein kinase or guanylyl cyclase activity). They play a major role in cell division, growth, inflammation, tissue repair, apoptosis and immune responses. Type 4: nuclear receptors (Hours) It is convenient to regard the entire nuclear receptor family as ligand-activated transcription factors that transduce signals by modifying gene transcription. They differ from other receptors because they are not embedded in membranes but are present in the soluble pahse of the cell. The term nuclear receptors is something of a misnomer, because some are actually located in the cytosol and migrate to the nuclear compartment when a ligand is present. Analogue: A compound that resembles another in structure but is not necessarily an isomer; analogues are often used to block enzymatic reactions by combining with enzymes. Enzymes: Enzymes are proteins, Enzymes are produced by living cells, Enzymes control all chemical processes of living systems. Enzymes are unique to one substrate, Enzymes combine with the substrate to form an enzyme substrate molecule. Substrate: The substance acted on and changed by an enzyme; the reactant considered to be attacked in a chemical reaction.